Successful treatment using agalsidase alfa of a patient with Fabry disease who had anaphylaxis after agalsidase beta: A case report.

IF 1.1 3区 历史学 Q2 ANTHROPOLOGY Archaeology in Oceania Pub Date : 2024-01-24 eCollection Date: 2024-01-01 DOI:10.14744/nci.2022.45656
Mehmet Erdem Cakmak
{"title":"Successful treatment using agalsidase alfa of a patient with Fabry disease who had anaphylaxis after agalsidase beta: A case report.","authors":"Mehmet Erdem Cakmak","doi":"10.14744/nci.2022.45656","DOIUrl":null,"url":null,"abstract":"<p><p>Fabry disease is a rare genetic disease caused by a deficiency of α-galactosidase A gene (α-Gal A). Two intravenous enzymes administered every two weeks, agalsidase alfa and beta can slow disease progression and increase survival if administered early, before organ damage occurs. In this case report, we present a patient with a history of anaphylaxis to agalsidase beta who was successfully treated with agalsidase alfa.</p>","PeriodicalId":46465,"journal":{"name":"Archaeology in Oceania","volume":"29 1","pages":"88-90"},"PeriodicalIF":1.1000,"publicationDate":"2024-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10861426/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archaeology in Oceania","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/nci.2022.45656","RegionNum":3,"RegionCategory":"历史学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ANTHROPOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Fabry disease is a rare genetic disease caused by a deficiency of α-galactosidase A gene (α-Gal A). Two intravenous enzymes administered every two weeks, agalsidase alfa and beta can slow disease progression and increase survival if administered early, before organ damage occurs. In this case report, we present a patient with a history of anaphylaxis to agalsidase beta who was successfully treated with agalsidase alfa.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
使用阿加西酶 alfa 成功治疗了一名在使用阿加西酶 beta 后出现过敏性休克的法布里病患者:病例报告。
法布里病是一种因缺乏α-半乳糖苷酶A基因(α-Gal A)而引起的罕见遗传病。每两周静脉注射两种酶,即α-阿加糖苷酶和β-阿加糖苷酶,如果能在器官损伤发生之前及早用药,可延缓疾病进展并提高存活率。在本病例报告中,我们介绍了一位曾对阿加西酶 beta 过敏的患者,她成功地接受了阿加西酶 alfa 的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.80
自引率
0.00%
发文量
24
期刊介绍: Archaeology in Oceania is published online and in print versions three times a year: April, July, October. It accepts articles and research reports in prehistoric and historical archaeology, modern material culture and human biology of ancient and modern human populations. Its primary geographic focus is Australia, the islands of the Pacific Ocean and lands of the western Pacific rim. All articles and research reports accepted as being within the remit of the journal and of appropriate standard will be reviewed by two scholars; authors will be informed of these comments though not necessarily of the reviewer’s names.
期刊最新文献
Issue Information A new parasite discovery in Micronesia: eggs of the nematode Toxocara canis at archaeological sites on Ebon Atoll, Marshall Islands extend the known dog presence by c.600 years The archaeology of eastern Lutruwita (Tasmania) Kia kōrerorero tonu ai: a review of the dialogue at the interface of Indigenous oral tradition and archaeology in Aotearoa New Zealand and Oceania The age and position of the southern boundary of prehistoric Polynesian dispersal
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1